24/7 Market News Snapshot 20 October, 2025 – Citius Oncology, Inc. Common Stock (NASDAQ:CTOR)
DENVER, Colo., 20 October, 2025 (www.247marketnews.com) – (NASDAQ:CTOR) are discussed in this article. Citius Oncology, Inc. is experiencing a notable...
DENVER, Colo., 20 October, 2025 (www.247marketnews.com) – (NASDAQ:CTOR) are discussed in this article. Citius Oncology, Inc. is experiencing a notable...
DENVER, Colo., 10/20/25 10:00 AM (247marketnews.com) – (NASDAQ: DVLT, NASDAQ: VRME, NASDAQ: CTXR, NYSE: DDD, NYSE: ANRO) are discussed in...
DENVER, Colo., Oct 20, 2025 (247marketnews.com)- As Wall Street stirs to life this morning, attention is shifting beyond big tech...
DENVER, Colo., 20 October, 2025 (www.247marketnews.com) – (NASDAQ:CRMD) are discussed in this article. CorMedix Inc. (Nasdaq: CRMD) has shown remarkable...
McKesson joins leading distribution service providers as authorized U.S. distributor of LYMPHIR CRANFORD, N.J., Oct. 20, 2025 /PRNewswire/ -- Citius...
Industry Veteran Steve La Neve Named Chief Executive Officer Suzanne Winter to Retire as President and CEO Company Appoints Steven...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on the development of novel precision...
DENVER, Colo., Oct 20, 2025 (247marketnews.com)- Kraig Biocraft Laboratories (OTCQB:KBLB) launched its sixth Spider Silk production cycle of 2025, debuting...
SOUTHLAKE, Texas, Oct. 20, 2025 /PRNewswire/ -- Sabre Corporation ("Sabre") (NASDAQ: SABR) will host a live webcast of its third...
DENVER, Colo., 20 October, 2025 (www.247marketnews.com) – (NYSE:ANRO) are discussed in this article. Alto Neuroscience Inc. is experiencing a surge...
DENVER, Colo., 10/20/25 09:00 AM (247marketnews.com) – (NASDAQ: BTBT, NASDAQ: GSIT, NYSE: ANRO, NASDAQ: VRME, NASDAQ: RXRX) are discussed in...
Transaction Expands Company's Footprint into Daytona Beach and Florida's East Coast DOTHAN, Ala., Oct. 20, 2025 /PRNewswire/ -- Construction Partners,...
DENVER, Colo., 20 October, 2025 (www.247marketnews.com) – (NYSE:ANRO) are discussed in this article. Alto Neuroscience Inc. has emerged as a...
TORONTO, Oct. 20, 2025 /PRNewswire/ - Full Circle Lithium Corp. ("FCL" or the "Company") (TSXV: FCLI) (OTCQB: FCLIF), a US-based...
SAN DIEGO, Oct. 20, 2025 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing...
DENVER, Colo., Oct 20, 2025 (247marketnews.com)- Wall Street is opening the week with a spotlight on experiential entertainment, oncology breakthroughs,...
VANCOUVER, BC, Oct. 20, 2025 /PRNewswire/ - Century Lithium Corp. (TSXV: LCE) (OTCQX: CYDVF) (Frankfurt: C1Z) ("Century Lithium" or "the Company") is...
McKesson joins leading distribution service providers as authorized U.S. distributor of LYMPHIR CRANFORD, N.J., Oct. 20, 2025 /PRNewswire/ -- Citius...
Seasoned global executive to drive expansion into AI data center infrastructure development LAS VEGAS, Oct. 20, 2025 /PRNewswire/ -- CleanSpark, Inc....
BEVERLY HILLS, Calif., Oct. 20, 2025 /PRNewswire/ -- Buscar Company (OTC: CGLD), through its wholly owned subsidiary Eon Discovery Inc.,...
NEW YORK, Oct. 20, 2025 /PRNewswire/ -- LivePerson (Nasdaq: LPSN), a leading provider of trusted enterprise conversational AI and outcome-driven...
Purchase Order with Returning Customer to Supply IR Camera Systems for Public Safety Applications ORLANDO, Fla., Oct. 20, 2025 /PRNewswire/...
Sunset Amphitheater Momentum and $5B Pipeline Plan Accelerate VENU’s National Rollout DENVER, Colo., Oct 20, 2025 (247marketnews.com)- VENU (NYSE:VENU), a...
ATR-01, which uses a filaggrin-secreting strain of S. epidermidis, is in preclinical development for ichthyosis vulgaris Preclinical data show production...
Expands global intellectual property coverage in markets with high breast cancer incidence New patent will provide IP protection of Breast...
VANCOUVER, BC, Oct. 20, 2025 /PRNewswire/ -- Zero Candida Technologies, Inc. (TSXV: ZCT) (OTCQB: ZCTFF) (FSE: 9L2) (the "Company" or "ZCT"), a...
NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Shutterstock, Inc. (NYSE: SSTK) ("Shutterstock") today received notice from the UK's Competition and...
TEL AVIV, Israel, Oct. 20, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical...
DENVER, Colo., 10/20/25 08:00 AM (247marketnews.com) – (NASDAQ: REPL, NASDAQ: ABAT, NASDAQ: DVLT, NASDAQ: GNLN, NYSE: AZTR) are discussed in...
FORT LAUDERDALE, Fla., Oct. 20, 2025 /PRNewswire/ -- Today, HoldCo Asset Management, LP ("HoldCo"), a Florida-based investment firm managing approximately...
The Company Plans To Report Earnings on November 17, 2025 BARCELONA, Spain, Oct. 20, 2025 /PRNewswire/ - Freightos Limited (NASDAQ:...
DENVER, Colo., 20 October, 2025 (www.247marketnews.com) – (NYSE:AZTR) are discussed in this article. Azitra Inc. has recently emerged as a...
DENVER, Colo., 20 October, 2025 (www.247marketnews.com) – (NASDAQ:BGLC) are discussed in this article. BioNexus Gene Lab Corp (Nasdaq: BGLC) is...
DENVER, Colo., 20 October, 2025 (www.247marketnews.com) – (NASDAQ:SPRC) are discussed in this article. SciSparc Ltd. (Nasdaq: SPRC) is currently demonstrating...
Sirexatamab demonstrated statistically significant improvement in PFS and OS in DKK1-high population Increasing DKK1 levels further improved PFS, OS, and...
KUALA LUMPUR, Malaysia, Oct. 20, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp (Nasdaq: BGLC, “BGLC”, or the “Company”), today...
DENVER, Colo., 20 October, 2025 (www.247marketnews.com) – (NASDAQ:SPRC) are discussed in this article. SciSparc Ltd. (NASDAQ: SPRC) is currently witnessing...
Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression free survival (mPFS) compared to 11.0 months mPFS with...
CALGARY, AB, Oct. 20, 2025 /PRNewswire/ - Westbridge Renewable Energy (TSXV: WEB) (OTCQX: WEGYF) (FRA: PUQ) announced today that it...
Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression free survival (mPFS) compared to 11.0 months mPFS with...